Attested · B01
Alex Gordon-Brander · Career and practice account
11 Nov 2026 · Alex’s biographical account
Alex described his original CFO and founding role at Algae Systems, his launch CEO role at XAIA and the practice traditions to include.
September 2023–February 2024 · Artificial minds · Documented · Biographical account or programme record
Alex led VRx Health as interim CEO during the launch of XAIA. The company was formed to commercialize work from Cedars-Sinai’s Virtual Medicine programme and licensed XAIA from Cedars-Sinai in January 2024. VRx Health later became Xaia Inc.
Attested · B01
11 Nov 2026 · Alex’s biographical account
Alex described his original CFO and founding role at Algae Systems, his launch CEO role at XAIA and the practice traditions to include.
Public · P38
2 Feb 2024 · Company announcement
Dates the spatial companion launch and identifies the Cedars-Sinai licence and founding team.
Public · P41
Public account · Company profile
Traces the development of the Cedars-Sinai Virtual Medicine programme, the SynerGI offering and formation of VRx Health.
Public · P44
Public terms · Company record
Identifies the corporate name history.
Public · P45
Role dates Sep 2023–Feb 2024 · Public professional profile
Alex’s published experience entry records the interim CEO role. The atlas also uses his direct account of the launch.
Recorded
The VRx Health company took forward the research programme’s technology during Alex’s tenure
Recorded
The launch occurred during Alex’s interim CEO tenure